Interview | WAMJ UPDATE | Page 21 of 24

ISSUE 4

FROM THE PUBLISHER Welcome to the fourth issue of WKMJ! In my role as the publisher of World Korean Medical Journal, I am blessed with...

J&J may suffer over AbbVie,Amgen in renewed biologic USpayer contracts as Celltrion’sbiosimilar loom

• Remsima use may be forced ahead of Remicade, but not Humira or Enbrel • Celltrion needs to emphasize Remsima clinical...

Array/Novartis’ Binimetinib Expected to Best Chemotherapy in Phase III Trial Despite Protocol Change

• Enrollment criteria expanded mid-trial to reflect shifting treatment landscape • Inhibiting MEK elicits enthusiasm for NRAS...

Why "New Standard" Ready to Use UK Injection Kit

UK Do-i, a Korea based pharmaceutical holding company is currently in process of establishing a local manufacturing facility through its...

Eyes on South Korea: A Rising Player in the Global Biopharmaceutical Industry

South Korea was highlighted as a collaboration destination at the Trans-Pacific Health Sciences Dialogue held in Philadelphia from...

Getting Back To The Scientific Principles in Clinical Decision Makings

Surge of thyroid cancer Like many other cancers, thyroid cancer incidence tends to be higher in wealthier regions of the world. The most...

Issue3

May 2014 - August 2014 June Ipca and Oncobiologics Create Strategic Biosimilars Partnership Ipca Laboratories Ltd., India and...

Congressman Chung Ui-Hwa’s Journey from Medicine to the National Assembly

What was your major reason for attending medical school? Why did you want to become a physician? While practicing as a physician, what...

Issue3

North America 40TH ANNIVERSARY CONFERENCE OF INTERNATIONAL SOCIETY FOR PEDIATRIC & ADOLESCENT DIABETES (ISPAD) SEPTEMBER 3RD TO 6TH...

The Unrealized Potential of Stem Cell Therapy

Over the last decade or so, I have observed a tempering of what was once a large and growing interest in stem cell therapies by patients,...

Subscribe to Our Journal